| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $847M | — | $817M | — | 3.7% |
| Op. Income | $267M | — | $83M | — | 223.1% |
| Gross Margin | 63.0% | — | 21.9% | — | 41.2pp |
| Net Margin | 23.1% | — | 7.5% | — | 15.6pp |
| EPS (Diluted) | $6.32 | — | $2.01 | — | 214.4% |
| Free Cash Flow | $174M | — | $79M | — | 120.8% |
| Item | Amount |
|---|---|
| REVENUE | $847M |
| Cost of Revenue | $313M |
| GROSS PROFIT | $534M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $93M |
| SG&A Expenses | $93M |
| Other Expenses | $182M |
| Operating Expenses | $275M |
| Cost & Expenses | $588M |
| OPERATING INCOME | $267M |
| Interest Income | $0 |
| Interest Expense | $8M |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $259M |
| Income Tax Expense | $64M |
| Net Income from Continuing Ops | $196M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $196M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $196M |
| D&A | $13M |
| EBIT | $267M |
| EBITDA | $280M |
| EPS | $6 |
| EPS Diluted | $6 |
| Item | Amount |
|---|---|
| REVENUE | $847M |
| Cost of Revenue | $313M |
| GROSS PROFIT | $534M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $93M |
| SG&A Expenses | $93M |
| Other Expenses | $182M |
| Operating Expenses | $275M |
| Cost & Expenses | $588M |
| OPERATING INCOME | $267M |
| Interest Income | $0 |
| Interest Expense | $8M |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $259M |
| Income Tax Expense | $64M |
| Net Income from Continuing Ops | $196M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $196M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $196M |
| D&A | $13M |
| EBIT | $267M |
| EBITDA | $280M |
| EPS | $6 |
| EPS Diluted | $6 |
| Item | Amount |
|---|---|
| Net Income | $196M |
| Depreciation & Amortization | -$779.0K |
| Stock-Based Compensation | $5M |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | $11M |
| Change in Working Capital | -$31M |
| OPERATING CASH FLOW | $182M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$345M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $312M |
| NET CASH FROM INVESTING | -$33M |
| Net Debt Issuance | -$36M |
| Common Stock Repurchased | -$2M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$2M |
| NET CASH FROM FINANCING | -$41M |
| FREE CASH FLOW | $174M |
| Net Change in Cash | $109M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $559M |
| Short-Term Investments | $0 |
| Net Receivables | $95M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $655M |
| PP&E (Net) | $46M |
| Goodwill | $0 |
| Intangible Assets | $30M |
| Long-Term Investments | $716M |
| Tax Assets | $6M |
| Other Non-Current Assets | -$716M |
| TOTAL NON-CURRENT ASSETS | $82M |
| TOTAL ASSETS | $2.2B |
| Account Payables | $0 |
| Short-Term Debt | $9M |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$4M |
| TOTAL CURRENT LIABILITIES | $4M |
| Long-Term Debt | $78M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $965M |
| TOTAL NON-CURRENT LIABILITIES | $1.1B |
| TOTAL LIABILITIES | $1.7B |
| Common Stock | $3.0K |
| Additional Paid-In Capital | $366M |
| Retained Earnings | $283M |
| Treasury Stock | -$133M |
| Accum. Other Comp. Income | -$11M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $505M |
| Minority Interest | $0 |
| TOTAL EQUITY | $505M |
| TOTAL LIABILITIES & EQUITY | $2.2B |
| Total Debt | $100M |
| Net Debt | -$459M |
